Cho, Sung-Min
Hwang, Jaeho
Chiarini, Giovanni
Amer, Marwa
Antonini, Marta V.
Barrett, Nicholas
Belohlavek, Jan
Brodie, Daniel
Dalton, Heidi J.
Diaz, Rodrigo
Elhazmi, Alyaa
Tahsili-Fahadan, Pouya
Fanning, Jonathon
Fraser, John
Hoskote, Aparna
Jung, Jae-Seung
Lotz, Christopher
MacLaren, Graeme
Peek, Giles
Polito, Angelo
Pudil, Jan
Raman, Lakshmi
Ramanathan, Kollengode
Dos Reis Miranda, Dinis
Rob, Daniel
Salazar Rojas, Leonardo
Taccone, Fabio Silvio
Whitman, Glenn
Zaaqoq, Akram M.
Lorusso, Roberto
Funding for this research was provided by:
NIH (1K23HL157610)
Article History
Received: 17 July 2024
Accepted: 28 August 2024
First Online: 6 September 2024
Declarations
:
: Not applicable as this is a consensus guidelines article.
: Dr. Cho is a consultant for Hyperfine, Inc. and supported by NIH (1K23HL157610 and 1R21NS135045). Dr. Brodie received research support from and consults for LivaNova. He has been on the medical advisory boards for Xenios, Medtronic, Inspira, and Cellenkos. He is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet), and he writes for UpToDate. Dr. Daniel is supported by MH CZ (DRO-VFN64165) and receives consulting honoraria from Abiomed and Resuscitec. Dr. Lorusso received research support from Medtronic and LivaNova, is consultant for Medtronic and Livanova, Member of the Medical Advisory Board of Eurosets and Xenios, and receives speaker fee from Abiomed.